Skip to main content

Health outcomes, education, healthcare delivery and quality – 3040. Occurrence and effects of nasal polyps in patients with bronchial asthma and/or allergic rhinitis

Background

The occurrence of nasal polyps (NP) in bronchial asthma (BA) and/or allergic rhinitis (AR) remains largely undiagnosed and adversely affects quality of life (QoL).

Methods

The study comprised 220 consecutive patients (males/females, 123/97), 15 to 60 years with BA and/or AR enrolled from outpatients department of VP Chest Institute, University of Delhi. BA/AR was diagnosed according to GINA/ARIA guidelines respectively. Group1 comprised 35 patients with BA, group2, 43 patients with AR and group3, 142 patients with both diseases. CT-PNS, done in all patients, assessed CRS/NP and was scored with Lund Mackey Score (LMS). To assess the effect of NP, asthmatics responded to asthma QoL questionnaire (MiniAQLQ), and the 15-17 years to MiniPAQLQ. Rhinitics responded to rhinoconjunctivitis QoL questionnaire (RQLQ) and the 15-17 years to AdolRQLQ. Patients with nasal symptoms responded to Sinonasal Outcome Test 22 (SNOT 22) and Visual Analogue Scale (VAS).

Results

Of the 220 patients, 190(86.4%) had CRS. Of these, 138(72.6%) had NP. CRS was seen in 26/35(74.3%) patients in group1, 38/43(88.4%), in group2 and 126/142(88.7%), in group3. NP was seen in 18/26(69.2%), 30/38(78.9%) and 90/126(71.4%) in groups 1, 2 and 3 respectively. The presence of NP increased mean LMS score from 5 in CRS to 8(P=0.005) in CRS/NP patients. In group2, occurrence of NP increased mean Global VAS score from 5 to 7(P=0.029), SNOT 22 scores from 43 to 44(P=0.029) and in RQLQ scores, activities score rose from 1.7 to 3.1(P=0.007), nasal symptom score from 3.9 to 4.1(P=0.033), non hayfever symptom score from 2.3 to 3.5(P=0.045) and RQLQ overall scores from 2.4 to 3.1(P=0.023). In group3, NP increased mean SNOT 22 scores from 39 to 42(P= 0.002), RQLQ nasal symptom score from 4.2 to 4.4(P=0.001) and RQLQ troubled sleep score from 1.7 to 1.9(P=0.021). There were no significant differences in group1. In all three groups, presence of NP increased mean RQLQ activities score from 3 to 3.3(P=0.033) and RQLQ troubled sleep score from 1.7 to 2(P=0.010).

Conclusions

NP was seen in nearly two-third (62.7%) of patients with BA and/or AR. QoL was maximally impaired when AR was complicated with NP followed by patients with both diseases.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Swati Behera.

Rights and permissions

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and Permissions

About this article

Cite this article

Behera, S. Health outcomes, education, healthcare delivery and quality – 3040. Occurrence and effects of nasal polyps in patients with bronchial asthma and/or allergic rhinitis. World Allergy Organ J 6, P213 (2013). https://doi.org/10.1186/1939-4551-6-S1-P213

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1186/1939-4551-6-S1-P213

Keywords

  • Bronchial Asthma
  • Visual Analogue Scale
  • Rhinitis
  • Allergic Rhinitis
  • Allergic Rhinitis